Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
PaperCitations, authors & open-access status
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 950 citations, 2014 year and green oa status.
950
Citations
2014
Year
green
OA Status